{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5079, "recent_count": 41, "transaction_limit": 160, "filters": {"q": "", "ticker": "ROIV", "sector": "", "industry": "", "side": "", "start": "2026-06-17", "end": "2026-08-01"}, "summary": {"total": 41, "acquisition_count": 8, "disposal_count": 33, "acquisition_value": 4787165.0, "acquisition_value_label": "$4.8M", "disposal_value": 202808518.38, "disposal_value_label": "$202.8M", "net_value": -198021353.38, "net_value_label": "$-198.0M", "flow_tone": "negative", "largest_value_label": "$20.8M", "top_sector": "Healthcare", "window_label": "17 Jun 2026 to 01 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 41, "value": "207595683.3800", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$207.6M"}], "days": [{"transaction_date": "2026-06-20", "acquisitions": 0, "disposals": 2, "total": 2, "bar_width": 20.0}, {"transaction_date": "2026-06-24", "acquisitions": 1, "disposals": 3, "total": 4, "bar_width": 40.0}, {"transaction_date": "2026-06-25", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 30.0}, {"transaction_date": "2026-06-26", "acquisitions": 1, "disposals": 8, "total": 9, "bar_width": 90.0}, {"transaction_date": "2026-06-29", "acquisitions": 1, "disposals": 9, "total": 10, "bar_width": 100.0}, {"transaction_date": "2026-06-30", "acquisitions": 1, "disposals": 9, "total": 10, "bar_width": 100.0}, {"transaction_date": "2026-07-17", "acquisitions": 3, "disposals": 0, "total": 3, "bar_width": 30.0}], "side_mix": {"acquisitions": 8, "disposals": 33, "acquisition_share": 19.5, "disposal_share": 80.5}}, "company_flows": [{"symbol": "ROIV", "name": "Roivant Sciences Ltd", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "acquisitions": 8, "disposals": 33, "acquired_value": 4787165.0, "acquired_value_label": "$4.8M", "disposed_value": 202808518.38, "disposed_value_label": "$202.8M", "net_value": -198021353.38, "net_value_label": "$-198.0M", "acquisition_share": 19.5, "disposal_share": 80.5, "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}], "company_overview": [{"symbol": "ROIV", "name": "Roivant Sciences Ltd", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "filings": 41, "acquisitions": 8, "disposals": 33, "acquired_value": 4787165.0, "acquired_value_label": "$4.8M", "disposed_value": 202808518.38, "disposed_value_label": "$202.8M", "net_value": -198021353.38, "net_value_label": "$-198.0M", "acquisition_share": 19.5, "disposal_share": 80.5, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}], "transactions": [{"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "EPPERLY, MELISSA B,", "executive_title": "Director", "security_type": "Common Shares", "side_code": "A", "side": "Acquisition", "shares": 543.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:10:43.123400+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "MOMTAZEE, JAMES C", "executive_title": "Director", "security_type": "Common Shares", "side_code": "A", "side": "Acquisition", "shares": 405.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:10:43.125491+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "OREN, ILAN", "executive_title": "Director", "security_type": "Common Shares", "side_code": "A", "side": "Acquisition", "shares": 775.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:10:43.120406+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "MANCHESTER, KEITH S", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 200000.0, "share_price": 35.45, "transaction_value": 7090000.0, "fetched_at": "2026-07-21T21:56:03.111759+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "GLINE, MATTHEW", "executive_title": "Director, CEO", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 76171.0, "share_price": 35.39, "transaction_value": 2695691.69, "fetched_at": "2026-07-21T21:56:03.115748+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "SUKHATME, MAYUKH", "executive_title": "Director, President & CIO", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 46878.0, "share_price": 35.39, "transaction_value": 1659012.42, "fetched_at": "2026-07-21T21:56:03.102094+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "TORTI, FRANK", "executive_title": "President and Vant Chair", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 40310.0, "share_price": 35.39, "transaction_value": 1426570.9, "fetched_at": "2026-07-21T21:56:03.104272+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "GOLD, DANIEL ALLEN", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 12380.0, "share_price": 35.28, "transaction_value": 436766.4, "fetched_at": "2026-07-21T21:56:03.113755+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "MANCHESTER, KEITH S", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 12380.0, "share_price": 35.28, "transaction_value": 436766.4, "fetched_at": "2026-07-21T21:56:03.107873+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "QVT, FINANCIAL LP", "executive_title": "Director by Deputization", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 12380.0, "share_price": 35.28, "transaction_value": 436766.4, "fetched_at": "2026-07-21T21:56:03.099756+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "FITZGERALD, MEGHAN", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 10000.0, "share_price": 34.9, "transaction_value": 349000.0, "fetched_at": "2026-07-21T21:56:03.106025+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "FITZGERALD, MEGHAN", "executive_title": "Director", "security_type": "Common Shares", "side_code": "A", "side": "Acquisition", "shares": 10000.0, "share_price": 8.8, "transaction_value": 88000.0, "fetched_at": "2026-07-21T21:56:03.117936+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "FITZGERALD, MEGHAN", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 10000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:56:03.109656+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "GOLD, DANIEL ALLEN", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 600000.0, "share_price": 34.59, "transaction_value": 20754000.0, "fetched_at": "2026-07-20T10:46:00.304871+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "MANCHESTER, KEITH S", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 600000.0, "share_price": 34.59, "transaction_value": 20754000.0, "fetched_at": "2026-07-20T10:46:00.308815+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "QVT, FINANCIAL LP", "executive_title": "Director by Deputization", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 600000.0, "share_price": 34.59, "transaction_value": 20754000.0, "fetched_at": "2026-07-20T10:46:00.300989+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "GOLD, DANIEL ALLEN", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 200000.0, "share_price": 34.44, "transaction_value": 6888000.0, "fetched_at": "2026-07-20T10:46:00.306742+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "MANCHESTER, KEITH S", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 200000.0, "share_price": 34.44, "transaction_value": 6888000.0, "fetched_at": "2026-07-20T10:46:00.311024+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "QVT, FINANCIAL LP", "executive_title": "Director by Deputization", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 200000.0, "share_price": 34.44, "transaction_value": 6888000.0, "fetched_at": "2026-07-20T10:46:00.303194+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "EPPERLY, MELISSA B,", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 15002.0, "share_price": 34.32, "transaction_value": 514868.64, "fetched_at": "2026-07-20T10:46:00.318123+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "EPPERLY, MELISSA B,", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 2748.0, "share_price": 34.71, "transaction_value": 95383.08, "fetched_at": "2026-07-20T10:46:00.315685+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "EPPERLY, MELISSA B,", "executive_title": "Director", "security_type": "Common Shares", "side_code": "A", "side": "Acquisition", "shares": 17750.0, "share_price": 4.46, "transaction_value": 79165.0, "fetched_at": "2026-07-20T10:46:00.298710+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "EPPERLY, MELISSA B,", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 17750.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-20T10:46:00.313133+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "SUKHATME, MAYUKH", "executive_title": "Director, President & CIO", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 500000.0, "share_price": 34.08, "transaction_value": 17040000.0, "fetched_at": "2026-07-16T11:01:59.317195+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "GOLD, DANIEL ALLEN", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 325000.0, "share_price": 34.07, "transaction_value": 11072750.0, "fetched_at": "2026-07-16T11:01:59.327736+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "MANCHESTER, KEITH S", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 325000.0, "share_price": 34.07, "transaction_value": 11072750.0, "fetched_at": "2026-07-16T11:01:59.324987+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "QVT, FINANCIAL LP", "executive_title": "Director by Deputization", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 325000.0, "share_price": 34.07, "transaction_value": 11072750.0, "fetched_at": "2026-07-16T11:01:59.319977+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "GOLD, DANIEL ALLEN", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 300783.0, "share_price": 33.92, "transaction_value": 10202559.36, "fetched_at": "2026-07-16T11:01:59.329320+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "MANCHESTER, KEITH S", "executive_title": "Director", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 300783.0, "share_price": 33.92, "transaction_value": 10202559.36, "fetched_at": "2026-07-16T11:01:59.326395+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "QVT, FINANCIAL LP", "executive_title": "Director by Deputization", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 300783.0, "share_price": 33.92, "transaction_value": 10202559.36, "fetched_at": "2026-07-16T11:01:59.321333+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "SUKHATME, MAYUKH", "executive_title": "Director, President & CIO", "security_type": "Common Shares", "side_code": "A", "side": "Acquisition", "shares": 500000.0, "share_price": 3.85, "transaction_value": 1925000.0, "fetched_at": "2026-07-16T11:01:59.323456+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "SUKHATME, MAYUKH", "executive_title": "Director, President & CIO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 500000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T11:01:59.318545+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "SUKHATME, MAYUKH", "executive_title": "Director, President & CIO", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 500000.0, "share_price": 34.13, "transaction_value": 17065000.0, "fetched_at": "2026-07-16T11:01:59.332731+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "SUKHATME, MAYUKH", "executive_title": "Director, President & CIO", "security_type": "Common Shares", "side_code": "A", "side": "Acquisition", "shares": 500000.0, "share_price": 3.85, "transaction_value": 1925000.0, "fetched_at": "2026-07-16T11:01:59.334126+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "SUKHATME, MAYUKH", "executive_title": "Director, President & CIO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 500000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T11:01:59.331134+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "VENKER, ERIC", "executive_title": "President & Immunovant CEO", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 153766.0, "share_price": 33.05, "transaction_value": 5081966.3, "fetched_at": "2026-07-14T21:51:30.635335+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "VENKER, ERIC", "executive_title": "President & Immunovant CEO", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 46234.0, "share_price": 33.51, "transaction_value": 1549301.34, "fetched_at": "2026-07-14T21:51:30.633459+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "VENKER, ERIC", "executive_title": "President & Immunovant CEO", "security_type": "Common Shares", "side_code": "A", "side": "Acquisition", "shares": 200000.0, "share_price": 3.85, "transaction_value": 770000.0, "fetched_at": "2026-07-14T21:51:30.629809+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "VENKER, ERIC", "executive_title": "President & Immunovant CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 200000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T21:51:30.631823+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-20", "executive": "HUMES, JENNIFER", "executive_title": "Chief Accounting Officer", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 3582.0, "share_price": 31.43, "transaction_value": 112582.26, "fetched_at": "2026-07-13T10:12:31.496112+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-20", "executive": "PULIK, RICHARD", "executive_title": "CFO", "security_type": "Common Shares", "side_code": "D", "side": "Disposal", "shares": 2129.0, "share_price": 31.43, "transaction_value": 66914.47, "fetched_at": "2026-07-13T10:12:31.497396+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}